Press release
Bronchial Hyperreactivity Market to Reach USD 2.2 Billion by 2034
Bronchial Hyperreactivity
Pune, India, November 2025 - Exactitude Consultancy reports that the Global Bronchial Hyperreactivity (BHR) Market is expected to reach USD 2.2 billion by 2034, growing at a CAGR of 5.7% from 2025 to 2034. The market expansion is driven by the rising global burden of asthma and chronic obstructive pulmonary disease (COPD), improvements in bronchodilator therapies, and growing use of airway reactivity testing in clinical diagnostics.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/72900
Bronchial hyperreactivity, a hallmark of asthma, is characterized by excessive narrowing of airways in response to triggers such as allergens, pollutants, or exercise. Growing emphasis on early detection, biomarker-based treatment, and digital spirometry solutions is enhancing disease management outcomes worldwide.
Key Takeaways
• Market Size: USD 1.25 billion in 2024 → projected USD 2.2 billion by 2034
• CAGR: 5.7% (2025-2034)
• Key Growth Drivers: Rising prevalence of asthma and COPD, precision respiratory medicine, and improved diagnostic accuracy
• Major Players: GlaxoSmithKline (GSK), AstraZeneca, Novartis AG, Boehringer Ingelheim, Teva Pharmaceutical Industries, Cipla Ltd., Sanofi, and Merck & Co.
• Top Regions: North America leads with 38% market share, while Asia-Pacific exhibits fastest CAGR (Less than 6.5%)
Market Story
The bronchial hyperreactivity market is closely linked to advancements in respiratory care and asthma therapeutics. Global asthma cases now exceed 340 million, underscoring the need for precise diagnostic tools and effective long-term management.
Pharmaceutical innovation continues to reshape the therapeutic landscape. AstraZeneca's Tezspire (tezepelumab) and GSK's Trelegy Ellipta are gaining momentum as next-generation biologics and combination inhalers for severe asthma and airway hyperreactivity. Meanwhile, digital spirometry and FeNO testing are becoming standard components of respiratory clinics, enabling earlier and more accurate detection of hyperresponsive airways.
Additionally, the rise of environmental pollution, urbanization, and occupational exposures is amplifying disease incidence in emerging economies, creating new growth opportunities for diagnostics and pharmaceutical firms alike.
Market Segmentation
By Type:
• Intrinsic (Non-Allergic) BHR
• Extrinsic (Allergic) BHR
By Diagnosis Method:
• Spirometry
• Methacholine Challenge Test
• Eucapnic Voluntary Hyperventilation Test
• Exhaled Nitric Oxide (FeNO) Test
By Treatment Type:
• Bronchodilators (β2-Agonists, Anticholinergics)
• Corticosteroids
• Biologics (Monoclonal Antibodies)
• Leukotriene Modifiers
By End User:
• Hospitals
• Pulmonary Clinics
• Research & Academic Institutions
By Region:
• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East & Africa
Explore Full Report here: https://exactitudeconsultancy.com/reports/72900/bronchial-hyperreactivity-market
Recent Developments
• October 2025: AstraZeneca expanded global access for Tezspire, a biologic for severe asthma, following new approvals across Asia and Latin America.
• August 2025: GSK announced strong clinical results for its triple-therapy inhaler Trelegy Ellipta in reducing bronchial reactivity and asthma exacerbations.
• June 2025: Novartis launched a Phase II trial evaluating QVM149 for hyperreactive airway management in adults.
• April 2025: Boehringer Ingelheim introduced an AI-supported spirometry device for enhanced diagnostic precision in primary care.
Expert Insight
"Bronchial hyperreactivity remains one of the most underdiagnosed respiratory conditions, yet it directly impacts millions of asthma patients," said Dr. Lina Mehta, Senior Respiratory Analyst at Exactitude Consultancy. "Advances in biologics, portable lung diagnostics, and digital inhaler technologies are reshaping how clinicians identify and manage airway hyperresponsiveness."
Get Your Exclusive Offer with up to 10% Discount : https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=72900
Market Drivers
• Rising asthma and COPD prevalence worldwide
• Technological advancements in pulmonary diagnostics and digital spirometry
• Growing demand for biologics and combination inhaler therapies
• Government initiatives to reduce air pollution and improve respiratory healthcare infrastructure
Forecast and Regional Outlook
North America dominates the BHR market due to high healthcare spending, widespread access to advanced respiratory therapies, and ongoing public awareness campaigns. Europe follows closely with strong clinical infrastructure and active research in immunological airway disorders.
Asia-Pacific is projected to grow fastest, supported by large patient populations in India and China, rising air pollution levels, and expanded access to affordable inhalation therapies.
Government and Institutional Initiatives
• U.S. NIH/NHLBI expanded funding under the Severe Asthma Research Program (SARP) to study airway hyperresponsiveness biomarkers.
• European Respiratory Society (ERS) introduced standardized BHR diagnostic guidelines in 2024.
• India's Ministry of Health launched the National Asthma Control Programme to promote early diagnosis and inhaler accessibility.
Conclusion
The Bronchial Hyperreactivity Market is witnessing a pivotal transformation as diagnostics, therapeutics, and digital health converge to improve respiratory care outcomes. With biologics gaining approval, portable testing devices entering clinics, and governments prioritizing lung health initiatives, the next decade promises significant progress in patient management and disease prevention.
This report is also available in the following languages : Japanese (気管支過敏症市場), Korean (기관지 과민반응 시장), Chinese (支气管高反应性市场), French (Marché de l'hyperréactivité bronchique), German (Markt für bronchiale Hyperreaktivität), and Italian (Mercato dell'iperreattività bronchiale), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @ https://exactitudeconsultancy.com/reports/72900/bronchial-hyperreactivity-market#request-a-sample
Related Reports
Esketamine Hydrochloride Market
https://exactitudeconsultancy.com/reports/66320/esketamine-hydrochloride-market
Brexpiprazole Market
https://exactitudeconsultancy.com/reports/66339/brexpiprazole-market
Psychosis Market
https://exactitudeconsultancy.com/reports/71019/psychosis-market
Schizoaffective Disorder Market
https://exactitudeconsultancy.com/reports/71022/schizoaffective-disorder-market
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
https://exactitudeconsultancy.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Bronchial Hyperreactivity Market to Reach USD 2.2 Billion by 2034 here
News-ID: 4257541 • Views: …
More Releases from Exactitude Consultancy
Mobile Application Market to Exceed USD 950 Billion by 2034
Pune, India - November 27, 2025 - Exactitude Consultancy announces the release of its latest report on the Global Mobile Application Market, highlighting strong growth driven by mobile-first user behavior, the rise of 5G networks, AI-powered personalization, digital payments, and an expanding smartphone user base. Leading industry innovators such as Google, Apple, Meta, ByteDance, Microsoft, Tencent, Amazon, Spotify, and Adobe continue to shape the future of global mobile apps across…
Online Lottery Market to Surpass USD 19.4 Billion by 2034
Pune, India - November 27, 2025 - Exactitude Consultancy has released its latest report indicating that the Global Online Lottery Market is set for strong expansion through 2030, driven by digital transformation in gaming, the rise of smartphone-based participation, secure online payment ecosystems, and government approvals for regulated e-lottery platforms. Key players such as Camelot Group, Lottoland, International Game Technology (IGT), Lotto Direct Limited, ZEAL Network, Sugal & Damani, and…
Mobile Wallet Market to Hit USD 6.7 trillion by 2034
Pune, India - November 27, 2025 - Exactitude Consultancy's latest research report highlights that the Global Mobile Wallet Market will experience exponential growth through 2030, driven by the rise of contactless payments, financial digitization, smartphone penetration, and government-led digital payment initiatives. Key innovators such as PayPal, Google Pay, Apple Pay, Samsung Pay, Amazon Pay, Alipay, WeChat Pay, PhonePe, and Paytm are reshaping how consumers and enterprises transact across the world.
Download…
Business Process Management (BPM) Market to Reach USD 20 Billion by 2034
Pune, India - November 27, 2025 - According to a new report by Exactitude Consultancy, the Global Business Process Management (BPM) Market is expected to witness significant growth by 2030, driven by rising automation demand, digital transformation initiatives, and the rapid adoption of AI-driven workflow orchestration. Companies worldwide are turning to BPM solutions to streamline operations, cut costs, enhance customer experiences, and accelerate time-to-market. Leading players include IBM, Appian, Pega,…
More Releases for Bronchial
Bronchial Spasm Market Outlook: Technological Advancements Reshape Treatment App …
The global bronchial spasm market is forecasted to expand at a compound annual growth rate (CAGR) of 6.2%, increasing from a valuation of US$387.4 million in 2024 to an estimated US$590.2 million by 2031. This growth trajectory marks a significant acceleration compared to the historical CAGR of 4.3% recorded from 2019 to 2023. The market's expansion is underpinned by a rising global prevalence of respiratory disorders such as asthma and…
Bronchial Spasms Market Expected to Reach USD 6.8 Billion by 2034
Bronchial spasms are a condition characterized by the sudden constriction of the muscles in the airways of the lungs, often leading to difficulty breathing, wheezing, and coughing. This condition is commonly associated with asthma, chronic obstructive pulmonary disease (COPD), and allergic reactions, but can also occur in response to environmental factors, infections, or irritants.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/71487
With the growing burden of asthma, COPD, and…
Bronchial Spasm Market Industry Size, Trends, and Growth Analysis Report 2024 - …
A new Report by CoherentMI Market Reports, titled "Bronchial Spasm Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2031,"" offers a comprehensive analysis of the industry, which comprises insights on the Bronchial Spasm market analysis. The report also includes competitor and regional analysis, and contemporary advancements in the market.
The bronchial spasm market is estimated to be valued at USD 14.1 Bn in 2024 and is expected to reach USD…
Bronchial Biopsy Devices Market to Witness Huge Growth by 2032
The "Bronchial Biopsy Devices Market" intelligence report, just published by USD Analytics, covers a micro-level study of important market niches, product offers, and sales channels. To determine market size, potential, growth trends, and competitive environment, the Bronchial Biopsy Devices Market provides dynamic views. Both primary and secondary sources of data were used to generate the research, which has both qualitative and quantitative depth. Several of the major figures the study…
Bronchial Biopsy Devices Market Increasing Demand, Growth Analysis and Future Ou …
The global bronchial biopsy devices market is anticipated to grow at a CAGR of 7.4% during the forecast period (2024-2031). Consistent FDA approval and continuous financial support are key drivers fostering growth in the bronchial biopsy devices market. The constant FDA approval attributes adherence to rigorous regulatory standards, instilling confidence in the safety and efficacy of these devices. In January 2023, Micronoma, INC., obtained FDA breakthrough device designation for OncobiotaLUNG,…
Bronchial Spasms Treatment Market: A Comprehensive Overview 2024-2032
The Bronchial Spasms Treatment Market is at the forefront of the healthcare landscape due to the escalating global prevalence of asthma. Asthma, a chronic respiratory condition characterized by bronchial spasms and airway inflammation, has become a significant public health concern. In 2021, the reported cases of asthma worldwide numbered nearly 283 million. The prevalence of this disease is projected to increase by a notable 4.0% during the forecast period of…
